Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: EC:2.5.1.47 (cysteine synthase)
 625 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Gastric mucous epithelial cells may represent a first line of defense against reactive oxygen species that are generated within the gastric lumen. However, little is known about their defenses against oxidant species. This study examined the importance of the glutathione (GSH) redox cycle and of endogenous catalase as antioxidant defenses in cultured gastric mucous cells. Cultured rat gastric mucous cells were exposed to H2O2 generated by glucose oxidase acting on glucose or to nascent H2O2 for 5 h. Cytotoxicity was quantified by measuring 51Cr release from prelabeled cells. The effects of inhibition of the GSH redox cycle and of endogenous catalase were examined. Glucose oxidase caused a dose-dependent increase of 51Cr release. Similarly, nascent H2O2 damaged the cells dose dependently. Pretreatment with 1,3-bis(chloroethyl)-1-nitrourea (inhibitor of GSH reductase) dose dependently increased glucose oxidase-induced 51Cr release. Preincubation with buthionine sulfoximine (inhibitor of gamma-glutamyl-cysteine synthetase), which lowered intracellular GSH content, enhanced glucose oxidase-induced damage in a dose-dependent manner. Pretreatment with diethyl maleate, which covalently binds GSH as catalyzed by GSH transferase, also enhanced the sensitivity to lysis by glucose oxidase. However, inhibition of endogenous catalase activity by 3-amino-1,2,4-triazole did not significantly alter glucose oxidase- or nascent H2O2-induced 51Cr release. These results suggest that the GSH redox cycle rather than endogenous catalase plays a critical role in intracellular antioxidant defense in cultured gastric mucous cells.
 ...
PMID:Antioxidant defenses of cultured gastric cells against oxygen metabolites: role of GSH redox cycle and endogenous catalase. 176 53

We have tested the tumoricidal potency of enzyme immunotoxins constructed of antibodies conjugated to glucose oxidase and to lactoperoxidase. Murine plasmacytoma cells were targeted in vitro with the use of affinity-purified rabbit anti-plasmacytoma membrane antibodies (conjugated to glucose oxidase or lactoperoxidase) or rabbit serum raised against plasmacytoma microsome membranes followed by goat anti-rabbit immunoglobulin conjugates (to glucose oxidase or lactoperoxidase). Cytotoxicity was generated subsequently by incubation of the washed cells in a medium supplemented with glucose and sodium iodide, which were the substrates of these enzymes. This resulted in the presumed metabolic release of highly toxic reduced oxygen species and iodinated derivatives. Targeting of tumor cells with both conjugates, as opposed to one of them alone, produced a synergistic killing effect. The gain of specific versus unspecific cytotoxicity was upwards of 10,000-fold. The killing rates were elevated (t10 values less than 30 min) and linear over time. The resultant reduction in tumor cell viability was in the order of 5 to 6 logs after only 20 to 90 min of incubation in the glucose/NaI medium. Cytotoxicity was enhanced by the gamma-glutamyl cysteine synthetase inhibitor buthionine-S,R-sulfoximine and by the glutathione reductase inhibitor 1,3-bis(2-chloroethyl)-1-nitrosourea, while catalase was inhibitory. The results suggest that these enzyme immunotoxins may be suitable for the ex vivo purging of autologous bone marrow grafts.
 ...
PMID:Immunotoxins containing glucose oxidase and lactoperoxidase with tumoricidal properties: in vitro killing effectiveness in a mouse plasmacytoma cell model. 279 Jul 77